Saturday, 25 May 2024
  
Login

Australia's most trusted
source of pharma news

Saturday, 25 May 2024
Listen to this story 
News

Pharma on $55B shopping spree

Posted 14 May 2024 PM

M&A activity is off to a strong start for 2024 with a total of AU$55 billion (US$36.46 billion) in upfront spending recorded for Q1, marking the fifth highest quarterly total since the beginning of 2020.

A new Evaluate report shows seven biopharma acquisitions valued at more than US$1 billion up front were recorded during Q1, including one above the US$10 billion mark.

To see the whole article, please login


Latest Jobs
Pharma in Focus  Jobs

Marketing & Communications (4)

Sales & Customer Relations (20)

Clinical & Medical, R&D (10)

Regulatory, Pharmacovigilance & QA (6)

Other (32)

MORE NEWS
Email this article to a friend
From:

 
 
  
Print this article

Copyright Notice

Please click the button to indicate that the printout of this article is for your personal use only and not for any type of redistribution.

Redistribution of the whole or part of Pharma in Focus by any means is a breach of copyright law.

Welcome to Pharma in Focus

Please log in to read.

Hi

Our old access system is being retired.

Please create a password and click 'Log in' for ongoing access.

Hi

Please choose a password to secure your access to Pharma in Focus (minimum 8 characters).

Hi

You're here because you requested to reset your password.

Please choose a new password (minimum 8 characters).

To search the News Archive you need to be logged in.

 

You can choose not to do this now but after November 30, a password will be required.

To learn more about the new-look Pharma in Focus click here.